文献速递心脑血管急症重症综合管理与镇静镇痛

SARS-CoV-2疫情期间院内缺血性卒中发生率增加:单中心研究

Increased Incidence of In-Hospital Ischemic Stroke During SARS-CoV-2 Outbreak: A Single-Center Study.
PubMed 文献 · Neurocrit Care · 2021-07-15
一句话结论COVID-19住院患者院内缺血性卒中绝对风险0.36%,校正后为历史非COVID队列的6.76倍,需警惕院内卒中。

该历史队列研究纳入8126例住院患者,比较COVID-19队列(CC)、同期2020非COVID队列(20NCC)及2016-2019历史非COVID队列(HNCC)的院内缺血性卒中(IHIS)发生率。IHIS绝对风险HNCC 0.05%、20NCC 0.23%、CC 0.36%(HNCC vs CC p=0.004);以死亡为竞争风险,入院第9天累积发生率分别为0.09%、0.23%、0.50%。校正性别、年龄、需ICU入住和队列后,COVID-19是IHIS独立预测因子(IRR 6.76,95%CI 1.66-27.54,p=0.01);20NCC风险升高但无统计学意义(IRR 5.62,95%CI 0.93-33.9,p=0.06)。提示COVID-19住院患者IHIS风险增加,病毒本身及医院饱和/医疗系统超负荷可能均起作用。

要点

  • COVID-19住院患者IHIS绝对风险0.36%,高于同期非COVID住院患者0.23%和历史非COVID住院患者0.05%(HNCC vs CC p=0.004)。
  • 以死亡为竞争风险,入院第9天IHIS累积发生率CC 0.50%、20NCC 0.23%、HNCC 0.09%。
  • 校正性别、年龄、需ICU入住和队列后,COVID-19是IHIS独立预测因子(IRR 6.76,95%CI 1.66-27.54,p=0.01)。
  • 同期2020非COVID住院患者IHIS风险也有升高趋势但无统计学意义(IRR 5.62,95%CI 0.93-33.9,p=0.06),提示医院饱和等系统因素可能参与。
  • COVID-19队列患者较HNCC和20NCC更年轻且男性更多。

适用人群与场景

  • SARS-CoV-2感染住院患者(COVID-19队列,2020年3-4月收治)。
  • 同期2020年3-4月非COVID-19内科疾病住院患者(20NCC)。
  • 2016-2019年3-4月非COVID-19疾病住院患者(HNCC,历史对照)。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:历史队列研究(COVID-19@Vallecas队列),单中心,共纳入8126例住院患者。
  • 人群:COVID-19住院患者(CC)、同期2020非COVID住院患者(20NCC)、2016-2019历史非COVID住院患者(HNCC);CC患者更年轻且男性更多。
  • 主要终点:IHIS绝对风险HNCC 0.05%、20NCC 0.23%、CC 0.36%(HNCC vs CC p=0.004)。
  • 竞争风险分析:入院第9天IHIS累积发生率HNCC 0.09%、20NCC 0.23%、CC 0.50%。
  • 校正Poisson回归(协变量:性别、年龄、需ICU入住、队列;HNCC为参照):COVID-19为IHIS独立预测因子(IRR 6.76,95%CI 1.66-27.54,p=0.01);20NCC风险升高但无统计学意义(IRR 5.62,95%CI 0.93-33.9,p=0.06)。

证据类型、等级与局限

  • 证据类型:单中心历史队列研究。
  • 局限:单中心、观察性设计;原文未提及证据等级或推荐强度。

对床旁实践的改变

  • 对COVID-19住院患者应警惕院内缺血性卒中,尤其住院早期(第9天累积发生率0.50%)。
  • 同期非COVID住院患者IHIS风险也有升高趋势,提示医院饱和/医疗系统超负荷可能参与,需关注系统因素对卒中识别和处置的影响。
  • 原文未提供筛查或预防性抗栓方案,不能据此推荐具体药物或监测阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Meta-analyses of observational studies report a 1.1-1.7% pooled risk of stroke among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requiring hospitalization, but consultations for stroke and reperfusion procedures have decreased during the outbreak that occurred during the first half of the year 2020. It is still unclear whether a true increase in the risk of stroke exists among patients with coronavirus disease 2019 (COVID-19). In-hospital ischemic stroke (IHIS) complicated the 0.04-0.06% of all admissions in the pre-COVID-19 era, but its incidence has not been assessed among inpatients with COVID-19. We aimed to compare IHIS incidence among patients with SARS-CoV-2 infection with that of inpatients with non-COVID-19 illnesses from the same outbreak period and from previous periods.

METHODS: This historical cohort study belongs to the COVID-19@Vallecas cohort. The incidence of IHIS was estimated for patients with SARS-CoV-2 hospitalized during March-April 2020 [COVID-19 cohort (CC)], for patients with non-COVID-19 medical illness hospitalized during the same outbreak period [2020 non-COVID-19 cohort (20NCC)], and for inpatients with non-COVID-19 illness admitted during March-April of the years 2016-2019 [historical non-COVID-19 cohort (HNCC)]. Unadjusted risk of IHIS was compared between the three cohorts, and adjusted incidence rate ratio (IRR) of IHIS between cohorts was obtained by means of Poisson regression.

RESULTS: Overall, 8126 inpatients were included in this study. Patients in the CC were younger and more commonly men than those from the HNCC and 20NCC. Absolute risk of IHIS was 0.05% for HNCC, 0.23% for 20NCC, and 0.36% for CC, (p = 0.004 for HNCC vs. CC). Cumulative incidence for IHIS by day nine after admission, with death as a competing risk, was 0.09% for HNCC, 0.23% for 20NCC, and 0.50% for CC. In an adjusted Poisson regression model with sex, age, needing of intensive care unit admission, and cohort (HNCC as reference) as covariates, COVID-19 was an independent predictor for IHIS (IRR 6.76, 95% confidence interval 1.66-27.54, p = 0.01). A nonsignificant increase in the risk of IHIS was observed for the 20NCC (IRR 5.62, 95% confidence interval 0.93-33.9, p = 0.06).

CONCLUSIONS: SARS-CoV-2 outbreak was associated with an increase in the incidence of IHIS when compared with inpatients from a historical cohort. Viral infection itself may be related to the increased risk of IHIS among patients with COVID-19, but in view of our results from the 20NCC, it is likely that other factors, such as hospital saturation and overwhelming of health systems, may have played a role in the increased frequency of IHIS.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Sierra-Hidalgo F, Aragón Revilla E, Arranz García P, et al. Increased Incidence of In-Hospital Ischemic Stroke During SARS-CoV-2 Outbreak: A Single-Center Study. Neurocrit Care. 2021. PMID: 34268645. doi:10.1007/s12028-021-01286-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。